Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review

AM Alsamil; TJ Giezen; TC Egberts; HG Leufkens; Arnold Vulto; MR van der Plas; H Gardarsdottir

doi:10.1016/j.ejps.2020.105501

Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review

AM Alsamil, TJ Giezen, TC Egberts, HG Leufkens, Arnold Vulto, MR van der Plas, H Gardarsdottir

Pharmacy

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

9 Downloads (Pure)

Original language	English
Article number	105501
Journal	European Journal of Pharmaceutical Sciences
Volume	154
DOIs	https://doi.org/10.1016/j.ejps.2020.105501
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1016/j.ejps.2020.105501

Repub_129407_O-A.pdfFinal published version, 864 KB

http://hdl.handle.net/1765/129407

Cite this

Alsamil, AM., Giezen, TJ., Egberts, TC., Leufkens, HG., Vulto, A., van der Plas, MR., & Gardarsdottir, H. (2020). Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review. European Journal of Pharmaceutical Sciences, 154, Article 105501. https://doi.org/10.1016/j.ejps.2020.105501

@article{e740a39b221c421f8e2d810e7f19678f,

title = "Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review",

author = "AM Alsamil and TJ Giezen and TC Egberts and HG Leufkens and Arnold Vulto and {van der Plas}, MR and H Gardarsdottir",

year = "2020",

doi = "10.1016/j.ejps.2020.105501",

language = "English",

volume = "154",

journal = "European Journal of Pharmaceutical Sciences",

issn = "0928-0987",

publisher = "Elsevier",

}

TY - JOUR

T1 - Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review

AU - Alsamil, AM

AU - Giezen, TJ

AU - Egberts, TC

AU - Leufkens, HG

AU - Vulto, Arnold

AU - van der Plas, MR

AU - Gardarsdottir, H

PY - 2020

Y1 - 2020

U2 - 10.1016/j.ejps.2020.105501

DO - 10.1016/j.ejps.2020.105501

M3 - Article

C2 - 32739253

SN - 0928-0987

VL - 154

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

M1 - 105501

ER -